EUVIMED · CrossrefJournal
Journal of Pharmacoepidemiology and Risk Management
ISSN 2005-3622 · Korean Society for Pharmacoepidemiology and Risk Management
Latest articles
Chemotherapy and the Risk of Dementia in Korean Breast Cancer Patients
Safety of Nirmatrelvir/Ritonavir in Pediatrics and Adolescents: Pharmacovigilance Study of VigiBase
Safety Monitoring of Hepatic and Renal Events with Potassium-Competitive Acid Blockers Using WHO VigiBase
Current Status of Safety Research on Glucagon-Like Peptide-1 Receptor Agonists for Obesity Treatment: A Scoping Review
A Comparative Analysis of Regulatory Approval and Safety Information for Major Anti-Obesity Medications in South Korea, the United States, Europe, and Japan
Analysis of Antidepressant-Related Adverse Events in National and International Literature: A Scoping Review
Regulatory and Case Analysis of Long-Term Follow-Up for Advanced Therapy Medicinal Products Based on the European Medicines Agency Post-Authorisation Safety Study
Disproportionality Analysis of Frequently Reported Adverse Events of Lipid-Modifying Agents Using a Community Pharmacy Database
Region-Specific Agomelatine-Associated Hepatic Disorder Signals Using the World Health Organization VigiBase Pharmacovigilance Database
Adverse Events of Glucagon-Like Peptide-1 Receptor Agonists for Obesity among South Korean Patients: A Prescription Sequence Symmetry Analysis
Recent Updates on Diagnosis and Prevention of Hypersensitivity Reactions to Iodinated Contrast Media
Methodologies for Health Risk Assessment of Mutagenic Impurities in Medications and the Role of Pharmacoepidemiology
Improving the Prescription System to Prevent Adverse Drug Reactions
Incidence and Risk Factors of Adverse Drug Reactions Related with Antimicrobials: A Single Center Study
Precautions for COVID-19 Vaccination
Comparison of Postmarket Surveillance Strategies of Implantable Medical Devices in the United States, European Union, and South Korea
The Safe Use of the COVID-19 Vaccine: Focusing on Allergic Reactions
Adverse Reactions after the Second Dose of ChAdOx1 COVID-19 Vaccine in Healthcare Workers
Drug Labeling Status of Culprit Drugs Inducing Severe Cutaneous Adverse Reactions
Surveillance of Adverse Drug Reactions to First-line Antituberculosis Drugs Using Common Data Model
Paradigm Shift of Pharmacovigilance: 10 Years’ Experience of Active Surveillance by One Regional Pharmacovigilance Center
Analysis of Adverse Drug Reactions to Common Drugs Administered to COVID-19 Patients: The Role of Pharmacovigilance System in Public Medical Centers
Adverse Effects of Opioids and Safe Prescription for Chronic Non-Cancer Pain
Comparison of Expedited Reporting System for Investigational Drugs in the U .S., EU and South Korea
The Current Status of the Organizations Dedicated to Post-marketing Safety Management of Pharmaceuticals
Diagnosis and Management of DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) Syndrome
Determining Whether a Drug Should Be Classified as Hazardous in Medical Institutions
An Overview of Multiple Drug Hypersensitivity Syndrome
Comparison of Uric Acid Elevation between Aspirin-Ticagrelor and Aspirin-Prasugrel during Dual Antiplatelet Therapy: A Pilot Study
Improvement of Re-examination System of New Drugs: A Safety Monitoring Study using Real-World Data on Re-examined Drugs
EUVIMED